Paper · 11069186
Crystal structure of fibroblast growth factor receptor ectodomain bound to ligand and heparin.
Pellegrini L and 4 others. Nature, 2000. Cited by 576 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Crystal structure of fibroblast growth factor receptor ectodomain bound to ligand and heparin. Papers, record 11069186. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/11069186
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics19
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Fibroblast Growth Factor 2 | Major topic |
| Heparin | Major topic |
| Receptor Protein-Tyrosine Kinases | Major topic |
| Receptors, Fibroblast Growth Factor | Major topic |
| Amino Acid Sequence | |
| Binding Sites | |
| Crystallography, X-Ray | |
| Escherichia coli | |
| Fibroblast Growth Factor 1 | |
| Humans | |
| Ligands | |
| Macromolecular Substances | |
| Models, Molecular | |
| Molecular Sequence Data | |
| Protein Binding | |
| Protein Conformation | |
| Protein Structure, Tertiary | |
| Receptor, Fibroblast Growth Factor, Type 2 | |
| Recombinant Proteins |
Source PubMed
Grants0
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
None in this release.
Trials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections0
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
None in this release.
References0
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
None in this release.
Cited by240
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 576 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,663,891 | FGF23 - A hormone produced by bone and has many faces. | Rev Endocr Metab Disord | 2026 | https://conductscience.org/library/papers/42663891 | PubMed |
| 42,559,254 | Reprogramming FGFR isoform specificity in FGF2 by deep mutational scanning. | Chem Sci | 2026 | https://conductscience.org/library/papers/42559254 | PubMed |
| 41,657,945 | Glycosaminoglycans in tissue regeneration: Insights into glycobiology and their biomedical application. | Bioact Mater | 2026 | https://conductscience.org/library/papers/41657945 | PubMed |
| 41,520,078 | Engineered fibroblast growth factor 1 variants uncouple glucose-lowering effects from mitogenic activity with therapeutic potential for type 2 diabetes. | Mol Biomed | 2026 | https://conductscience.org/library/papers/41520078 | PubMed |
| 41,245,879 | Heparan sulfate as a central modulator of growth factor dynamics in tissue regeneration. | APL Bioeng | 2025 | https://conductscience.org/library/papers/41245879 | PubMed |
| 40,779,638 | Heparan sulfate fine-tuned interleukin-1 (IL-1) signaling inhibits insulin secretion of grafted pancreatic islets. | Sci Adv | 2025 | https://conductscience.org/library/papers/40779638 | PubMed |
| 40,585,885 | High-Fat Diet Differentially Regulates Fibroblast Growth Factor Expression in Metabolic Tissues of Young and Aged Male Mice. | J Endocr Soc | 2025 | https://conductscience.org/library/papers/40585885 | PubMed |
| 40,497,953 | FGF-Mediated Axon Guidance: Role of Downstream Signaling Pathways in Cytoskeletal Control. | Cells | 2025 | https://conductscience.org/library/papers/40497953 | PubMed |
| 40,437,501 | Reprogramming FGF1 from the natural growth factor to the engineered heparan sulphate biosensor. | Cell Commun Signal | 2025 | https://conductscience.org/library/papers/40437501 | PubMed |
| 40,257,501 | Increased thermal stability of FGF10 leads to ectopic signaling during development. | Cell Mol Life Sci | 2025 | https://conductscience.org/library/papers/40257501 | PubMed |
1 to 10 of 240
See all 240 cited byGenes5
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| FGF1 | 2,246 | Swiss-Prot's references | https://conductscience.org/library/genes/2246 | NCBI Gene |
| FGFR2 | 2,263 | Swiss-Prot's references | https://conductscience.org/library/genes/2263 | NCBI Gene |
| GPC3 | 2,719 | PubTator's text mining | https://conductscience.org/library/genes/2719 | NCBI Gene |
| MYB | 4,602 | PubTator's text mining | https://conductscience.org/library/genes/4602 | NCBI Gene |
| RET | 5,979 | PubTator's text mining | https://conductscience.org/library/genes/5979 | NCBI Gene |
Drugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data1
The data bank entries PubMed's record names. Trial numbers are under Trials.
| Data bank | Accession |
|---|---|
| PDB | 1E0O |
Source PDB
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/11069186
GET https://conductscience.org/api/papers/v1/11069186/cited_by?page=2